Eli Lilly and Co says John Johnson will lead the oncology business unit. Johnson currently serves as chief executive officer of ImClone Systems. Lilly also announced that Enrique Conterno will lead the diabetes business unit, Bryce Carmine will lead the established markets business unit and Jeffrey Simmons will lead Elanco, the animal health business unit. The new roles will become effective on Nov. 1, 2009.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Compelling solutions through strategic partnerships
